242 results
8-K
EX-10.2
r6nx2
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
qvmc17txtnt5xxrl
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
EX-99.1
fn9yf37 v7nj5srg
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-10.2
9ji92ih93vn
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
6ikoj5
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
bge1u0d3
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
i1a9 53z5i7iiw
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
2zoorrpslql pfzshby
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
v03lybs8r rede
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
x6w2swz
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
EX-99.2
pdw3t1
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am